title: Epoetins and mortality in patients with cancer.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nonoguchi
authors.forename: Yoshinaga
authors.initials: Y
authors.lastname: Otaki
authors.forename: Masanori
authors.initials: M
authors.lastname: Tokuyama
authors.forename: Satoshi
authors.initials: S
authors.lastname: Yamamoto
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nakanishi
mesh_terms: D000740:Anemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000009:adverse effects*; D006454:Hemoglobins / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000401:mortality*; D018579:Patient Selection; D011994:Recombinant Proteins; D015996:Survival Rate
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin